Nurosene is committed to finding solutions that will advance science, improve patient outcomes, and empower people suffering from poor mental health around the globe.
Dedicated to supporting you to live a healthier today and brighter tomorrow.
The Problem
78%
Nearly 8 in 10 adults (78%) say the coronavirus pandemic is a significant source of stress in their life.
264M
People are affected by depression globally. More women are affected than men and depression is one of the main causes of disability worldwide.
75-85%
People with mental disorders receive no treatment because of stigma, cost and accessibility.
The Opportunity
$310 Billion
The global mHealth apps market size is expected to reach USD $310 billion by 2027. Benefits that improve lifestyle and treatment outcomes is one of the key factors driving the growth of this market. Ref.
Why Nurosene?
Nurosene is committed to providing tools and technology that empower individuals to take control of and enhance their mental wellness. Our mission is to build the next generation of better, healthier brains.
Investor Presentation
Board & Advisors
Corporate Directory
Nurosene
[Head Office]
1655 Dupont St. #Suite 101
Toronto, ON M6P 3S9
investors@nurosene.com
Fasken Martineau DuMoulin LLP
[Legal]
2400 - 333 Bay St.
Toronto, ON M5H 2T6
416.366.8381
MNP LLP
[Auditors]
111 Richmond St. W Suite 300
Toronto, ON M5H 2G4
416.596.1711
Odyssey Trust
[Transfer Agent]
United Kingdom Building 323
409 Granville Street
Vancouver, BC V6C 1T2
1.833.392.7716